TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Early-stage Breast Cancer
Related studies linked through entity extraction aliases.
Breast Cancer Exercise Intervention Study
- Status
- RECRUITING
- Phase
- NA
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab
- Status
- RECRUITING
- Phase
- PHASE3
Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE4
Evaluation of Hydroxychloroquine to Prevent CIPN
- Status
- WITHDRAWN
- Phase
- PHASE2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
- Status
- RECRUITING
- Phase
- PHASE2
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
- Status
- COMPLETED
- Phase
- NA
Cardioprotective Effect of Acute Exercise in Breast Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Cardiometabolic Screening Program
- Status
- RECRUITING
- Phase
- NA
Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
- Status
- RECRUITING
- Phase
- PHASE2
Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Axillary Staging in Early Breast Cancer: SNB vs PET/MRI
- Status
- COMPLETED
- Phase
- NA
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4